← SynDRA
NAPHAZOLINE
SynDRA canonical compound SYN0001734 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | ADRA1A | ADRA2A |
| Mechanism of action | adrenergic receptor agonist |
| Indication | eye irritation |
| Disease area | ophthalmology |
All known targets
- ADRA2A
- ADRA1A
- ADRA2C
- ADRA2B
- ADRA1B
- ADRA1D
- Adra1a
- Adra1b
- Adra1d
- Adra2a
- Adra2b
- Adra2c
Mechanisms of action (all sources)
- ADRA1A AGONIST
- Adrenergic receptor alpha agonist
- ADRA2A AGONIST
- ADRA2C AGONIST
- ADRA1D AGONIST
- ADRA1B AGONIST
- ADRA2B AGONIST
- ADRA1A FULL AGONIST
- ADRA2A PARTIAL AGONIST
- adrenergic receptor agonist
- DRD2 AGONIST
Drug classes
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic alpha-Agonists
- Cardiovascular Agents
- Nasal Decongestants
- Neurotransmitter Agents
- Respiratory System Agents
- Vasoconstrictor Agents
ATC classes
- R01A · DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
- S01G · DECONGESTANTS AND ANTIALLERGICS
Cross-references
Synonyms
- naphazoline nitrate
- naphthazoline
- naphthizine
- nephazoline
- rhinazine
- naphazoline hydrochloride
- naphazoline HCl
- Nafazolina
- Nafazolin
- Antan
- Clearine
- Nafazoline
- Naphazolinum
- Naphthizine
- Opcon
- Nafazolina [DCIT]
- Nafazoline [Spanish]
- Naphazoline Monohydrochloride
- Naphazolinum [Latin]
- Enamine_000333
- Alpha-Naphthylmethyl imidazoline
- Ciba 2020/R
- Nafazolin (TN)
- Naphazoline (INN)
- Naphazoline [INN:BAN]
- Naphazolinum [INN-Latin]
- AK-968/41090774
- 2-(1-Naphthylmethyl)-2-imidazoline
- 2-(1-Naphthylmethyl)-4,5-dihydro-1H-imidazole
- 2-(Naphthyl-(1')-methyl)imidazolin
- 2-(Naphthyl-(1')-methyl)imidazolin [German]
- 2-(alpha-Naphthylmethyl)-imidazoline
- 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole
- 4,5-Dihydro-2-(1-naphthylmethyl)imidazole
- H231GF11BV
- 1H-Imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-
- alpha-Naphthylmethyl imidazoline
- DTXCID90198485
Reported adverse events
Look up NAPHAZOLINE in the interactive SynDRA portal →